Skip to main content

Ikarian Capital, LLC

Position in EYPT — EyePoint, Inc.

CIK 1778253 DALLAS, TX

Position in EYPT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$21,641 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
10 quarters on record

Common Shares in EYPT Over Time

Shares Held

Position Value (USD)

Derivatives in EYPT

reported options exposure · as of Mar 31, 2026
CallValue
$4,774,456
CallShares
370,400
PutValue
$4,774,456
PutShares
370,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $659,799,686 across 106 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in EYPT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,774,456 370,400
2026-03-31 $4,774,456 370,400
2024-03-31 $4,268,355 206,500
2024-03-31 $21,641 1,047
2024-03-31 $13,604,994 658,200
2023-12-31 $8,507,484 368,130
2023-12-31 $6,544,752 283,200
2023-12-31 $9,036,010 391,000
2023-09-30 $35,851 4,487
2022-03-31 $274,006 22,552
2021-12-31 $262,266 21,427
2021-09-30 $379,569 36,427
2021-06-30 $1,874,415 208,500
2021-06-30 $1,080,013 120,135
2021-03-31 $1,220,571 120,135
2021-03-31 $2,118,360 208,500
2020-12-31 $117,782 17,900